Screening for inhibitors of Cholesteryl Ester Transfer Protein
Screening for inhibitors of Cholesteryl Ester Transfer Protein
批准号:
09480147
负责人:
TOMODA Hiroshi
金额:
$2.88万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1999
中文摘要
Cholesteryl ester transfer protein (CETP) promotes exchange and transfer of neutral lipids such ascholesteryl ester (CE)和TG between plasma lipoproteins. Evidence has been accumulating of theimportance of CETP in atherosclerosis. Thereforeinhibition of CETP是proposed as a novel target for anti-atherosclerotic drugs. Interestingly,the mechanism of CETP-mediated lipid transfer is still unclear. In fact,small molecules modulating the CETP activity been searched for extensively for therapeutic andbiochemical purposes.Over twenty thousand samples of microbial culture broths subjected to ourscreening program for CETP inhibitors. Finally,我们发现的错误从一个fungal strain,and ferroverdins from an actinomycete strain,正如novel CETP inhibitors.我们也观察已知的功能metabolites,sclerotiorin originally isolated as a yellow pigment and L681512 compounds isolated as elastaseinhibitors, inhibit CETP activity.From the model reaction,sclerotiorin can react with a primary amine such as N-terminal cysteine and/or lysines in CETPmolecule to form a covalent bond Among CETP inhibitors of natural origin ferroverdin B show verypotent CETP inhibition with a nanomolar IC - D250 - D2 value. Ex体内efficacy was shown usingtransgenic mice for sclerotiorin and L681512。
英文摘要
Cholesteryl ester transfer protein (CETP) promotes exchange and transfer of neutral lipids such as cholesteryl ester (CE) and TG between plasma lipoproteins. Evidence has been accumulating of the importance of CETP in atherosclerosis. Therefore, inhibition of CETP is proposed as a novel target for anti-atherosclerotic drugs. Interestingly, the mechanism of CETP-mediated lipid transfer is still unclear. In fact, small molecules modulating the CETP activity have been searched for extensively for therapeutic and biochemical purposes.Over twenty thousand samples of microbial culture broths were subjected to our screening program for CETP inhibitors. Finally, we discovered erabulenols from a fungal strain, and ferroverdins from an actinomycete strain, as novel CETP inhibitors. We also observed that known fungal metabolites, sclerotiorin originally isolated as a yellow pigment and L681512 compounds isolated as elastase inhibitors, inhibit CETP activity.From the model reaction, sclerotiorin can react with a primary amine such as N-terminal cysteine and/or lysines in CETP molecule to form a covalent bond. Among CETP inhibitors of natural origin ferroverdin B show very potent CETP inhibition with a nanomolar ICィイD250ィエD2 value. Ex vivo efficacy was shown using transgenic mice for sclerotiorin and L681512.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
N. Tabata, H. Tomoda, and S. Omura: "Erabulenols A and B, inhibitors cholesteryl ester transfer protein, produced by Penicillium sp. FO-5637. II.Structure elucidation of erabulenols A and B"J. Antibiot. 51. 624-628 (1998)
N. Tabata、H. Tomoda 和 S. Omura:“Erabulenols A 和 B,胆固醇酯转移蛋白抑制剂,由青霉属 sp. FO-5637 产生。II.erabulenols A 和 B 的结构阐明”J。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
N.Tabata, H.Tomoda, and S.Omura: "Erabulenoles A and B, inhibitors of cholesteryl ester transfer protein, produced by Penicillium sp. FO-5637. II. Structure elucidation of erabulenols A and B"J. Anitibiot.. 51. 624-628 (1998)
N.Tabata、H.Tomoda 和 S.Omura:“Erabulenoles A 和 B,胆固醇酯转移蛋白抑制剂,由青霉属 sp. FO-5637 产生。II.erabulenoles A 和 B 的结构阐明”J。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
N.Tabata,H.Tomoda,Y.Yamaguchi,R.Masuma: "Inhibition of cholesteryl ester transfer protein by fungal metabolites, L681.512"J.Antibiot.. 52. 1042-1045 (1999)
N.Tabata,H.Tomoda,Y.Yamaguchi,R.Masuma:“真菌代谢物对胆固醇酯转移蛋白的抑制,L681.512”J.Antibiot.. 52. 1042-1045 (1999)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
N.Tabata, H.Tomoda,S.Omura: "Ferroverdins, Inhibitors of cholesteryl ester transfer protein produced by Streptomyces sp.WK-5344.II.Structure elucidation"J.Antibiot.. 52. 1108-1113 (1999)
N.Tabata、H.Tomoda、S.Omura:“Ferroverdins,链霉菌属 sp.WK-5344 产生的胆固醇酯转移蛋白的抑制剂。II.结构阐明”J.Antibiot.. 52. 1108-1113 (1999)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tomoda,H., Tabata,N., et al.: "Erabulenoles A and B, inhibitors of cholesteryl ester transfer protein, produced by Penicillium sp. FO-5637. II. Structure elucidation of erabulenoles A and B" J.Antibiot. 51. 624-628 (1998)
Tomoda,H., Tabata,N., et al.:“Erabulenoles A 和 B,胆固醇酯转移蛋白抑制剂,由青霉属 sp. FO-5637 产生。II.erabulenoles A 和 B 的结构阐明”J.Antibiot。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 21 条
THE CHEMICAL BIOLOGY OF NEW MICROBIAL ANTI-INFECTIVE AGENTS
-
批准号:21310146
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.07万
-
财政年份:2009
-
负责人:TOMODA Hiroshi
-
依托单位:
Discovery and development of selectivity-defined inhibitors toward two acyl-CoA : cholesterol acyltransferase isozymes
-
批准号:18390008
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.11万
-
财政年份:2006
-
负责人:TOMODA Hiroshi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
丹参酮ⅡA联合miR-29b inhibitor调控TGF-β1 / Smad3协同促进肌腱功能修复的机制研究
-
批准号:81702135
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卢荟
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
石斑鱼凋亡抑制因子Bax inhibitor 1(BI-1)在虹彩病毒SGIV侵染中的功能研究
-
批准号:31402335
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2014
-
负责人:蔡佳
-
依托单位:
水稻愈伤组织分化相关蛋白的分离及其功能研究
-
批准号:31201189
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2012
-
负责人:朱克明
-
依托单位:
miRNAs调控炎性因子抑制成骨分化的机理与种植体周应用研究
-
批准号:81170988
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2011
-
负责人:黄慧
-
依托单位:
谷氨酸的耳蜗毒性机制及干预研究
-
批准号:81070783
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:龚树生
-
依托单位:
糖尿病外周神经病变发生及评估治疗效果的实验室指标研究
-
批准号:81060141
-
项目类别:地区科学基金项目
-
资助金额:25.0万元
-
批准年份:2010
-
负责人:杨红英
-
依托单位:
PKB/AKT1介导的结核杆菌感染及防治的分子机制研究
-
批准号:30871117
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2008
-
负责人:范红
-
依托单位: